The Blockbuster That Wasn't -- A CETP Inhibitor Post-Mortem

The quest for the “holy grail” of cardiovascular therapy - a drug that dramatically lowered LDL-c and raised HDL-c and which would hopefully reverse atherosclerosis - has ended ignominiously.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

LDL [+]    HDL [+]   

More #news: